Alcohol, heart disease, and mortality: a review
- PMID: 12439349
Alcohol, heart disease, and mortality: a review
Abstract
Observational data suggest that moderate alcohol consumption is associated with reduced all-cause mortality compared with that associated with either abstinence or heavy drinking. Alcohol consumption reduces cardiovascular disease risk primarily by increasing production of high-density lipoprotein cholesterol, and possibly by increasing plasminogen, tissue plasminogen activator, and endothelial function, and decreasing platelet aggregability, fibrinogen, and lipoprotein(a). Red wine, containing antioxidants, has been purported to be especially cardioprotective. However, red wine consumption is not associated with reduced all-cause mortality in European countries, and American studies have found no relationship between the type of alcohol consumed and cardiovascular risk. Alcohol appears to be more cardioprotective if consumed with meals (possibly owing to protection against postprandial endothelial protection) and in moderation daily (as opposed to binge drinking). Despite the wealth of observational data, it is not absolutely clear that alcohol reduces cardiovascular risk, because no randomized controlled trials have been performed. Alcohol should never be recommended to patients to reduce cardiovascular risk as a substitute for the well-proven alternatives of appropriate diet, exercise, and drugs. Alcohol remains the number three cause of preventable premature death in this country, and the risk of alcohol habituation, abuse, and adverse effects must be considered in any patient counseling.
Similar articles
-
[Alcohol and wine and cardiovascular diseases in epidemiologic studies].Przegl Lek. 2009;66(5):233-8. Przegl Lek. 2009. PMID: 19739580 Review. Polish.
-
[Alcohol, lipid metabolism and coronary heart disease].Herz. 1996 Aug;21(4):217-26. Herz. 1996. PMID: 8805001 Review. German.
-
Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease.Eur J Clin Nutr. 2005 Mar;59(3):449-55. doi: 10.1038/sj.ejcn.1602107. Eur J Clin Nutr. 2005. PMID: 15674304 Clinical Trial.
-
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.Angiology. 2007 Dec-2008 Jan;58(6):689-97. doi: 10.1177/0003319707306146. Angiology. 2007. PMID: 18216378
-
Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".Semin Thromb Hemost. 2010 Feb;36(1):59-70. doi: 10.1055/s-0030-1248725. Epub 2010 Apr 13. Semin Thromb Hemost. 2010. PMID: 20391297 Review.
Cited by
-
Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.Drugs. 2005;65(1):31-74. doi: 10.2165/00003495-200565010-00003. Drugs. 2005. PMID: 15610050 Review.
-
Association of Dietary Flavonoid Intake with Serum Cotinine Levels in the General Adult Population.Nutrients. 2023 Sep 25;15(19):4126. doi: 10.3390/nu15194126. Nutrients. 2023. PMID: 37836410 Free PMC article.
-
Multifactorial 10-Year Prior Diagnosis Prediction Model of Dementia.Int J Environ Res Public Health. 2020 Sep 14;17(18):6674. doi: 10.3390/ijerph17186674. Int J Environ Res Public Health. 2020. PMID: 32937765 Free PMC article.
-
Beneficial effects of Chinese herbs in the treatment of fatty liver diseases.J Tradit Complement Med. 2020 Mar 2;10(3):260-267. doi: 10.1016/j.jtcme.2020.02.008. eCollection 2020 May. J Tradit Complement Med. 2020. PMID: 32670821 Free PMC article. Review.
-
The Effects of Flavonoids in Cardiovascular Diseases.Molecules. 2020 Sep 21;25(18):4320. doi: 10.3390/molecules25184320. Molecules. 2020. PMID: 32967119 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical